Crestline Management, L.P. — 13F Holdings & Portfolio
CIK 1536054 · latest 13F-HR filed 2026-08-14
Crestline Management, L.P. manages $53.5M in 13F-reported U.S. long-equity assets across 3 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are DNLI (91.90%), SANA (4.93%), EGHT (3.17%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 0, added to 2, and trimmed 0.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
SUITE 2100
FORT WORTH, TX 76102
$53.5M
Long-equity book
3
Distinct positions
2026-06-30
Filed 2026-08-14
+0 / −0 / ↑2 / ↓0
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- DENALI THERAPEUTICS INC$6.7M +15.8%
- SANA BIOTECHNOLOGY INC$461.1K +21.2%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $53.5M | 3 | 0001315863-26-000592 |
| 2026-03-31 | 2026-05-15 | $46.3M | 3 | 0001315863-26-000422 |
| 2026-03-31 | 2026-05-15 | $46.3M | 3 | 0001315863-26-000412 |
| 2025-12-31 | 2026-02-17 | $53.3M | 3 | 0001315863-26-000165 |
| 2025-09-30 | 2025-11-14 | $58.1M | 3 | 0001315863-25-000800 |